CIK 0001158895 · Large accelerated filer
LEMAITRE VASCULAR INC
Sign in to watch- Ticker
- LMAT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- operating
- Phone
- 781-221-2266
- Business address
- 63 SECOND AVENUE, BURLINGTON, MA, 01803
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-04 | LeMaitre George W Chairman and CEO | Grant or award | +11,974 | 45,374 | ||
| 2026-06-04 | LeMaitre George W Chairman and CEO | Grant or award · Dividend Equivalent Rights | +4.01 | 49.33 | ||
| 2026-06-04 | LeMaitre George W Chairman and CEO | Grant or award · Dividend Equivalent Rights | +4.01 | 48.62 | ||
| 2026-06-04 | LeMaitre George W Chairman and CEO | Grant or award · Dividend Equivalent Rights | +6.85 | 57.35 | ||
| 2026-06-04 | LeMaitre George W Chairman and CEO | Grant or award · Dividend Equivalent Rights | +8.21 | 60.86 | ||
| 2026-06-04 | LeMaitre George W Chairman and CEO | Grant or award · Dividend Equivalent Rights | +10.03 | 53.38 | ||
| 2026-06-04 | LeMaitre George W Chairman and CEO | Grant or award · Dividend Equivalent Rights | +11.36 | 53.84 | ||
| 2026-06-04 | LeMaitre George W Chairman and CEO | Grant or award · Dividend Equivalent Rights | +16.81 | 31.02 | ||
| 2026-05-08 | LeMaitre George W Chairman and CEO | Sale | −27,881 | $108.69 | $3.0M | 1,430,019 |
| 2026-05-08 | Kamke Trent G Senior V. P., Operations | Sale | −2,928 | $107.00 | $313K | 3,749 |
| 2026-05-07 | LeMaitre George W Chairman and CEO | Sale | −18,600 | $107.64 | $2.0M | 1,457,900 |
| 2026-05-07 | Ross Bridget A Director | Option exercise | +3,444 | $48.60 | $167K | 7,386 |
| 2026-05-07 | Ross Bridget A Director | Option exercise | +1,600 | $47.19 | $76K | 8,986 |
| 2026-05-07 | Ross Bridget A Director | Sale | −5,044 | $111.10 | $560K | 3,942 |
| 2026-05-07 | Ross Bridget A Director | Option exercise · Stock Option (Right to Buy) | −3,444 | 0 | ||
| 2026-05-07 | Ross Bridget A Director | Option exercise · Stock Option (Right to Buy) | −1,600 | 1,609 | ||
| 2026-05-07 | Jasinski Lawrence J Director | Option exercise | +1,069 | $47.19 | $50K | 6,868 |
| 2026-05-07 | Jasinski Lawrence J Director | Option exercise | +924 | $54.65 | $50K | 7,792 |
| 2026-05-07 | Jasinski Lawrence J Director | Option exercise | +865 | $101.12 | $87K | 8,657 |
| 2026-05-07 | Jasinski Lawrence J Director | Sale | −3,943 | $110.00 | $434K | 4,714 |
Page 6 of 46 · 910 trades